SCHEMBL14849752

SCHEMBL14849752

Cc1ccc(-c2nc(-c3ccccn3)c([C@@H]3CC[C@H](c4ccccc4)NC3)[nH]2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRCP P42785 6/20 0.66
▸ RAF1 P04049 2/20 0.38
▸ TGFBR1 P36897 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ AURKA O14965 2/20 0.36
▸ NPY5R Q15761 2/20 0.35
▸ GFER P55789 2/20 0.35
▸ MAPK13 O15264 2/20 0.35
▸ MAPK12 P53778 2/20 0.35
▸ MAPK11 Q15759 2/20 0.35
▸ MAPK14 Q16539 2/20 0.35
▸ GCGR P47871 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14849873 0.93 PRCP (0.69) PRCPRAF1TGFBR1AURKANPY5R
SCHEMBL14849804 0.93 PRCP (0.69) PRCPRAF1TGFBR1AURKANPY5R
SCHEMBL14849667 0.90 PRCP (0.81) PRCPRAF1TGFBR1AURKAMAPK13
SCHEMBL14849764 0.90 PRCP (0.81) PRCPRAF1TGFBR1AURKAMAPK13
SCHEMBL14856996 0.90 PRCP (0.81) PRCPRAF1TGFBR1AURKAMAPK13
SCHEMBL14849684 0.90 PRCP (0.81) PRCPRAF1KDM4EMEN1KMT2A
SCHEMBL14849783 0.80 PRCP (1.00) PRCPRAF1AURKAMAPK13MAPK12
SCHEMBL14849781 0.80 PRCP (1.00) PRCPRAF1AURKAMAPK13MAPK12
SCHEMBL14849688 0.71 PRCP (0.79) PRCPRAF1TGFBR1AURKANPY5R
SCHEMBL14849801 0.71 PRCP (0.76) PRCPKDM4EKMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006268-B2 Prolylcarboxypeptidase inhibitors MERCK SHARP & DOHME CORP. (US) 2015-04-14 — — US disclosed
US-20130090324-A1 NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS MERCK SHARP & DOHME LLC 2013-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090324-A1 NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS PRCP, PREP, ENPEP PRCP 1/4885RAF1 3742/4885TGFBR1 3064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback